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, both negative regulators of cell prodifferent promoters (Duro et al., 1995; Stone et al., 1995a ; liferation. We report the phenotype of mice carrying a Mao et al., 1995) . Each transcript has a specific 5Ј exon, targeted deletion of the INK4a locus that eliminates E1␣ or E1␤, which is spliced into common exons E2 and both p16
INK4a and p19 ARF . The mice are viable but de-E3. The E1␣-containing transcript encodes p16
INK4a
, and velop spontaneous tumors at an early age and are the E1␤-containing transcript encodes p19 ARF from a different reading frame initiated in the E1␤ exon (Quelle highly sensitive to carcinogenic treatments. INK4a-et al., 1995a) . p19 ARF has the ability to arrest cell proliferadeficient primary fibroblasts proliferate rapidly and tion at both G1 and G2, albeit through mechanisms not have a high colony-formation efficiency. In contrast involving direct inhibition of known CDK-cyclin comwith normal cells, the introduction of activated Ha-ras plexes (Quelle et al., 1995a) . Another level of complexity into INK4a-deficient fibroblasts can result in neoplasat the INK4a locus results from its close physical proximtic transformation. These findings directly demonity to the gene encoding p15
INK4b
, an inhibitor thought strate that the INK4a locus functions to suppress neoto play an integral role in transforming growth factor plastic growth.
(TGF)␤-induced cell-cycle arrest (Hannon and Beach, 1994) .
Introduction
The involvement of p16 INK4a in the development of human tumors was implied by the observation that the The cell cycle is controlled by the sequential activation INK4a locus (also called MTS1, CDK4I, or CDKN2) is and inactivation of protein kinases known as cyclinmutated in many tumor-derived cell lines and maps to dependent kinases (CDKs) (reviewed by Hunter and a chromosomal region frequently altered in human maPines, 1994). Each CDK associates with a cyclin subunit, lignancies (Kamb et al., 1994; Nobori et al., 1994 ; Okawhich is essential for catalytic activity and probably submoto et al., 1994) . A vast amount of data has since strate recognition. Among the members of the cyclin accumulated implicating the loss of p16 INK4a function in family, D1 was isolated as an oncogene and as a possithe development of a wide spectrum of tumors. Several ble effector of mitogen-induced proliferation acting durmechanisms of p16 INK4a inactivation have been characing the G1 phase of the cell cycle (Motokura et al., 1991;  terized whose prevalence varies with the type of tumor. Xiong et al., 1991; Matsushime et al., 1991) . The predomPoint mutations and small deletions are common in inant CDK partners activated by cyclin D1 are the closely pancreatic adenocarcinomas, esophageal carcinomas, related kinases CDK4 and CDK6 (Matsushime et al., biliary tract cancers, and in families with hereditary sus-1992; Xiong et al., 1992; Meyerson and Harlow, 1994;  ceptibility to melanoma and pancreatic cancer (reBates et al., 1994) . The activity of these kinases is subviewed by Pollock et al., 1996; and by Hirama and Koeffler, 1995 ; see also Yoshida et al., 1995;  Hussussian et ject to additional levels of regulation, including the assoal., 1994; Goldstein et al., 1995; Whelan et al., 1995) . In ciation with inhibitory subunits (reviewed by Morgan, general, the mutations in the INK4a locus that have been 1995; Sherr and Roberts, 1995) . One such inhibitor, identified to date affect p16 INK4a either exclusively ‫)%05ف(‬ or together with p19 ARF (Quelle et al., 1995a) . In the particular case of Dutch and Australian families with *The first two authors contributed equally to this work.
hereditary melanoma, most of the INK4a-predisposing 1). In normal cells, CDK4 is a component of at least mutations are located in exon E1␣, thus affecting exclutwo different multiprotein complexes: an active complex sively p16
INK4a (Gruis et al., 1995; Walker et al., 1995;  consisting of CDK4, cyclin D1, p21, and proliferating cell Holland et al., 1995) . A large proportion of the point nuclear antigen (PCNA), in which PCNA is brought into mutations found in the INK4a locus are nonsense in the complex through association with the carboxytermithe frame encoding p16
INK4a (up to 45% in melanomas; nal domain of p21; and an inactive complex consisting reviewed by Pollock et al., 1996) , whereas no nonsense of CDK4 and p16 INK4a (Xiong et al., 1993 ; reviewed by mutations have been found in p19 ARF (Quelle et al., Sherr and Roberts, 1995) . These two complexes were 1995a). A second type of p16
INK4a inactivation consists present in anti-CDK4 immunoprecipitates from INK4a ϩ/ϩ of large homozygous deletions that eliminate the INK4a MEFs ( Figure 1C , lanes 7 and 8). In contrast, CDK4 was locus and, in most cases, also involve INK4b ‫;%08ف(‬ associated with cyclin D1, p21, and PCNA, but not with Stone et al., 1995b) . Homozygous deletions are common p16 INK4a in INK4a Ϫ/Ϫ cells ( Figure 1C , lanes 9 and 10). in non-small cell lung carcinomas, malignant gliomas, Although the labeling of p21 is weak, its presence in the renal cell carcinomas, head and neck tumors, prostate complexes can be inferred by the coimmunoprecipitatumors, bladder carcinomas, and acute lymphoblastic tion of PCNA. Anti-CDK6 immunoprecipitates also releukemias (reviewed by Hirama and Koeffler, 1995; see vealed the presence of p16 INK4a in INK4a ϩ/ϩ but not in also Orlow et al., 1995; Gonzalez-Zulueta et al., 1995a;  INK4a Ϫ/Ϫ MEF lysates ( Figure 1C , compare lanes 2 and Williamson et al., 1995; Cairns et al., 1995) . Finally, meth-3 with lanes 5 and 6). These results confirm that the ylation of the INK4a locus is common in breast and colon INK4a Ϫ/Ϫ mice do not carry INK4a, and that loss of cancers and results in silencing of the p16
INK4a promoter p16 I NK 4 a does not produce di scern ible additi onal (Herman et al., 1995; Gonzalez-Zulueta et al., 1995b) , changes in the composition of CDK4 and CDK6 combut not of the p19 ARF promoter (Mao et al., 1995 (Silvers, 1979) . This complexity preand E3 (Quelle et al., 1995b) served as a source of homolsently precludes a precise assessment of the possible ogous sequences for the construction of a positive/negimpact of INK4a deficiency on melanocyte function until ative replacement-type vector, p16KO, in which exons fully inbred strains are generated. On i nspection, E2 and E3 were replaced with a neo r cassette ( Figure 1A ). INK4a Ϫ/Ϫ organs aged 2 months or younger were normal p16KO was electroporated into WW6 mouse embryonic in size and appearance. However, histological analysis stem (ES) cells (Ioffe et al., 1995) , and one clone was of the spleen revealed a mild proliferative expansion of identified that contained restriction fragment-length althe white pulp and the presence of numerous megakaryterations consistent with disruption of the INK4a locus ocytes and lymphoblasts in the red pulp (data not (see also Figure 1B , lanes 1-3). This ES clone was used shown). These features are consistent with abnormal to generate germline chimeras following microinjection extramedullary hematopoietic processes in the spleen into C57BL/6 blastocysts. (Quelle et al., 1995b) . The p19 ARF -specific exon E1␤ is indicated with an open box (Quelle et al., 1995a) and has been placed upstream of exon E1␣ based on the location of human E1␤ (Duro et al., 1995; Stone et al., 1995a; Mao et al., 1995) . Abbreviations for restriction endonucleases: P, PstI; S, SalI; Sc, SacI; N, NotI; Nh, NheI; B, BamHI; X, XbaI. The precise positions of two PstI sites in the 5Ј-region (2P) and one PstI site in the 3Ј-region (P) have not been determined. Homologous recombination replaces exons E2 and E3 with the pgk-neo cassette and introduces PstI and XbaI sites. of n ϭ 13) developed histologically confirmed tumors at for its carcinogenic effects in mice (reviewed by Kripke, 1994) . In the selection of these protocols, we took into an average age of 29 weeks during an observation period of 36 weeks ( Figure 2A ; Table 1 ). In contrast, none account the fact that C57BL/6 mice are poorly susceptible to the development of papillomas and squamous of their INK4a ϩ/ϩ or INK4a ϩ/Ϫ littermates developed any obvious tumors or displayed compromised health after cell carcinomas in the skin induced by standard twostage carcinogenic treatments with DMBA initiation and 36 weeks.
The susceptibility of each genotype to tumor induction phorbol ester promotion (reviewed by DiGiovanni, 1991).
In the DMBA/UVB-treated cohort, only 10% of INK4a
by carcinogens was assessed using three different treatments: a two-stage protocol consisting of a single applimice remained free of obvious tumors or compromised health during an observation period of 20 weeks (Figure cation of 9,10-dimethyl-1,2-benzanthracene (DMBA) followed by repeated irradiation with ultraviolet B (UVB) 2B). Specifically, twenty INK4a Ϫ/Ϫ mice were followed: twelve mice developed clinically apparent and histologi-(280-320 nm); treatment with DMBA alone; and exposure to UVB alone. DMBA is a well-characterized mutacally confirmed malignancy (see Table 1 ); three mice died suddenly for unknown reasons and a comprehengen and carcinogen that forms covalent DNA adducts (reviewed by DiGiovanni, 1991) . The relationship besive histological survey failed to identify tumor formation; finally, three mice died without clinically apparent tween UVB exposure and carcinogenic response is well documented (de Gruijl and van der Leun, 1991); in additumors but advanced autolysis precluded an informative histological analysis. The average latency of tumor fortion to its action as a mutagen, UVB induces a marked systemic immunosuppression that is partly responsible mation in the group of twelve mice with histologically marker protein ( Figure 3B) , keratins, or desmin (data not shown); these results indicate that these tumors are not melanomas, carcinomas, or myogenic sarcomas, respectively. However, cells were positive for vimentin, thus favoring the diagnosis of fibrosarcoma ( Figure 3C ). Another type of vimentin-positive sarcoma showed characteristic features of a highly vascularized angiosarcoma with neoplastic cells in the lumina of ill-defined vessels (data not shown). The second major histological tumor category exhibited a more generalized distribution and primarily involved lymphoid organs. The normal architecture of the affected lymph nodes was completely effaced by small round cells with hyperchromatic nuclei, prominent nucleoli, scanty cytoplasm, and numerous and bizarre mitotic figures. These tumor cells displayed positive surface immunostaining with anti-CD45 and B220 antibodies, but were unreactive with anti-CD3, establishing the diagnosis of B cell lymphoma ( Figures 3D, 3E , and 3F; data not shown). The spectra of tumor types arising in untreated animals and in carcinogen-treated animals were similar, although three proved to be well-differentiated squamous cell carcino-(B) DMBA/UVB-treated mice.
mas (see Table 1 ). In summary, mice lacking INK4a are (C) DMBA-treated mice. In the INK4a Ϫ/Ϫ group, three mice develparticularly susceptible to the development of sarcomas oped clinically apparent tumors, and two mice died without clinically and lymphomas.
apparent tumors but could not be subjected to autopsy due to autolysis. In the INK4a ϩ/Ϫ group, one mouse developed a tumor, and one mouse died but could not be subjected to autopsy due to
Growth Properties of INK4a
Ϫ/Ϫ MEFs autolysis.
Two observations point to a role for INK4a as a regulator of normal fibroblast growth. First, INK4a-deficient mice confirmed malignancies was 9 weeks. In comparison, develop fibrosarcomas with high frequency (see Table  83% of the twenty-three INK4a ϩ/Ϫ mice and 100% of 1) and, second, p16 INK4a appears to be the major INK4 the twenty-seven INK4a ϩ/ϩ littermates remained healthy protein associated with CDK4 and CDK6 in normal and tumor-free, although occasional histologically bemouse embryonic fibroblasts (see Figure 1C ). Accordnign papillomas were observed. Four INK4a ϩ/Ϫ mice deingly, we have studied the growth properties of primary veloped slow-growing histologically verified tumors with MEFs derived from individual embryos. Cultures of an average latency of 15 weeks (see Table 1 ). In the INK4a Ϫ/Ϫ MEFs were morphologically indistinguishable group of animals treated with DMBA alone, the percentfrom INK4a ϩ/ϩ MEFs. Early-passage INK4a Ϫ/Ϫ MEFs grew age of survival was higher and the latency of tumor significantly faster than early-passage INK4a ϩ/ϩ or development was longer than that of the DMBA/UVB INK4a ϩ/Ϫ MEFs, and the INK4a Ϫ/Ϫ MEFs monolayers group (e.g., latency was 13 weeks for INK4a Ϫ/Ϫ mice; achieved higher cellular densities ( Figure 4A ). Compared Figure 2C , legend). The group of INK4a Ϫ/Ϫ mice treated with INK4a ϩ/ϩ MEFs, analysis of the different cell cycle with UVB alone developed tumors with kinetics that were stages during exponential growth revealed a moderate indistinguishable from those of the untreated mice (64% increase in the S phase population of the INK4a Ϫ/Ϫ MEFs, of mice developed tumors at an average age of 28 weeks accompanied by a concomitant decrease in the G0/G1 during an observation period of 36 weeks, nϭ11; see population ( Figure 4B ). A quantitatively similar change Figure 2A ). This suggests that UVB potentiates the carcion cell-cycle distribution has been reported for Rb Ϫ/Ϫ nogenicity of DMBA but, when used alone under the MEFs (Lukas et al., 1995b) . conditions employed, is not tumorigenic (compare Fig- The ability of primary cell cultures to produce colonies ures 2A, 2B, and 2C). None of the UVB-treated INK4a ϩ/ϩ of clonal origin is related to the proliferative potential of or INK4a ϩ/Ϫ mice have developed tumors (data not the cells (Kraemer et al., 1986; Conzen and Cole, 1995) . shown). Together, these findings demonstrate that the INK4a Ϫ/Ϫ early-passage MEFs formed colonies more effiabsence of INK4a results in increased susceptibility to ciently than INK4a ϩ/ϩ MEFs ( Figure 4C ), suggesting that the development of cancers.
INK4a Ϫ/Ϫ cells can overcome senescence more easily At the histopathological level, the spectrum of tumors than their wild-type counterparts. Normal primary MEFs in the INK4a Ϫ/Ϫ mice is dominated by two tumor types initially grow at a constant rate until they enter into a (see Table 1 ). One, arising in the subcutis and invading slow-growth phase, or senescence, when they reach the underlying musculature, is composed of anaplastic a population doubling level (PDL) of approximately 10 spindle cells with frequent mitotic figures ( Figure 3A) .
doublings (Rö hme, 1981; Conzen and Cole, 1995) . SponSince these features are consistent with either melataneous escape from senescence occurs in normal ronoma, leiomyosarcoma, or fibrosarcoma, we further dent cells at a measurable frequency (frequency per cell defined the histogenesis with a battery of immunohisto-‫2ف‬ ϫ 10 6 ) (Kraemer et al., 1986). Serial passage of two chemical markers. Tumor cells did not show immunoreactivity to antibodies against protein S100, a melanocyte independent INK4a -/-MEF cultures resulted in a constant Figure 3 ; SCC: squamous cell carcinoma. d Numbers indicate the presence of more than one tumor of the same type. e These two mice also had significantly elevated peripheral white blood cell counts and lymphoid or myeloid blast-like cells on peripheral blood smears, which were suggestive of an associated leukemic state.
and rapid growth rate with no detectable senescent at two different levels (Land et al., 1983 ; reviewed by phase and reaching PDLs equal to 56 and 57, respec Hunter, 1991) . Compared with rat cells, neoplastic transtively, after 25 passages. A total of five independent formation of primary MEFs occurs inefficiently and has INK4a ϩ/ϩ and INK4a ϩ/Ϫ MEF cultures reached PDLs been observed only with particular pairs of cooperating ranging from 17-33 after 25 passages and showed a oncogenes (e.g., Ha-ras val12 /E1a and Ha-ras val12 /CDC25A; transitory slow-growth phase of variable duration at Lowe et al., 1994; Galaktionov et al., 1995) . PDLs equal to around 12 (data not shown). Although
As anticipated, transfection of Ha-ras val12 or myc into senescence of the INK4a Ϫ/Ϫ cells was not detectable at early-passage INK4a ϩ/ϩ or INK4a ϩ/Ϫ MEFs failed to prothe population level, individual cells could be identified duce transformed foci (Table 2) . Interestingly, focus forshowing morphological signs of senescence such as mation was observed in the INK4a Ϫ/Ϫ monolayers after prominent cytoplasmic enlargement. These observatransfection with Ha-ras val12 but not after transfection tions, together with the higher colony-formation effiwith myc (Table 2; Figure 5A ). Figure 5B ) and to produce tumors quires the cooperation of pairs of oncogenes, reflecting the necessity to disregulate cell proliferation minimally in nude mice (data not shown). These results indicate that INK4a deficiency can cooperate with activated HaDiscussion ras to induce the malignant transformation of primary fibroblasts, and further suggest that loss of INK4a may
The hypothesis that p16 INK4a is a tumor suppressor is based on three existing lines of evidence: p16
INK4a nerepresent an immortalization event in the transformation of primary fibroblasts.
gates the activity of a known oncogene, cyclin D1, and has the capacity to arrest cell proliferation at G1 in an ( Lee et al., 1992; Jacks et al., 1992; Clarke et al., 1992 ).
e ND: not done.
INK4a
Ϫ/Ϫ mice develop spontaneous tumors at an early age ‫%96ف(‬ of the mice before reaching 36 weeks Table 2 . (B) Colony-formation assay in soft agar. Left, wt-8 (INK4a ϩ/ϩ ) MEFs; middle, dko-6 (INK4a Ϫ/Ϫ ) MEFs; right, cells from a focus produced by introduction of Ha-ras val12 into dko-6 (INK4a Ϫ/Ϫ ) MEFs. Cells from 2 out of 3 randomly chosen dko-6/Ha-ras val12 foci were able to produce colonies in soft agar.
of age, and with an average age of 29 weeks) and, comsingle regulatory pathway. This pathway can be altered by inactivation of p16 INK4a or Rb, or by amplification of pared with their INK4a ϩ/ϩ and INK4a ϩ/Ϫ littermates, are highly susceptible to the development of tumors followthe genes encoding CDK4 or cyclin D1. A particular missense mutation in CDK4 that specifically disrupts ing carcinogenic treatments (DMBA/UVB, and DMBA alone). Although the number of tumors analyzed is limthe p16 INK4a binding site has been found in sporadic melanomas and also in families with hereditary susceptibility ited, it is clear that INK4a Ϫ/Ϫ mice are particularly susceptible to development of soft-tissue sarcomas and to melanoma who do not carry mutant INK4a alleles (Wö lfel et al., 1995; Zuo et al., 1996) . Moreover, there B cell lymphomas. Inactivation of the INK4a gene is common in human lymphomas and sarcomas (reviewed are some tumor types in which alteration of one component of the p16
/CDK4/D1/Rb pathway occurs in exby Hirama and Koeffler, 1995) . In addition, the histologically aggressive nature of the fibrosarcomas arising in clusivity with respect to the alteration of the other components (Jiang et al., 1993; Okamoto et al., 1994; INK4a Ϫ/Ϫ mice, as judged by overall architecture, degree of cellular atypia, and mitotic indices, contrasts sharply Schmidt et al., 1994; Maelandsmo et al., 1995; Shapiro et al., 1995b; He et al., 1995; Ueki et al., 1996) . This with the relatively nonaggressive histological picture seen in the low-grade fibrosarcomas arising in INK4a , 1991) . p16KO was electroporated into WW6 ES cells (Ioffe et al., 1995) , and clones were selected with G418 (150 g/ml (DiGiovanni, 1991; Bradl et al., 1991) . . In support of a role for the INK4a locus in estabperformed as described (Xiong et al., 1993) . The antiserum against lishing cellular mortality, p16 INK4a expression has been murine p16 (Quelle et al., 1995b) tion, a property that is characteristic of immortal rodent cell lines (Land et al., 1983; Newbold and Overell, 1983;  UVB and DMBA Tumorigenic Treatments Palmieri, 1989; Ruley, 1990; Hunter, 1991) . These find- The results presented in this paper directly demon- (1992) . Serum-, TPA, and counted after the indicated days. For colony-formation efficiency, Ras-induced expression from Ap-1/Ets-driven promoters requires 3.5 ϫ 10 3 cells were distributed on a total of 10 dishes of 6 cm Raf-1 kinase. Genes Dev. 6, 545-556. diameter and incubated in DMEM plus 15% FBS. After 8 days, Cairns, P., Polascik, T.J., Eby, Y., Tokino, K., Califano, J., Merlo, A., dishes were stained with Giemsa, and the number of visible colonies Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J.L., Buckler, (>1.5 mm of diameter) was scored. Serial cultures were done ac-A., Gabrielson, E., Tockman, M., Cho, K.R., Hedrick, L., Bova, G.S., cording to the 3T9 protocol. In brief, 10 6 cells were plated on a 6 Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. (1995) . Frecm diameter dish in DMEM plus 10% FBS, and after 3 days the quency of homozygous deletion at p16/CDKN2 in primary human resultant number of cells was counted and 10 6 cells were plated tumours. Nature Genet. 11, 210-212. again; this procedure was repeated for 25 passages.
Clarke, A.R., Maandag, E.R., van Roon, M., van der Lugt, N.M.T., (1994) . Expression of the retinomg/ml of RNAse A for 30 min at 37ЊC; 2 M HCl, 0.5% Triton X-100 blastoma protein is regulated in normal human tissue. Am. J. Pathol. for 30 min at room temperature; FITC-conjugated anti-BrdU (Becton 144, 500-510. Dickinson) diluted 1:5 for 1 hr at room temperature; and, finally, 5
de Gruijl, F.R., and van der Leun, J.C. (1991). Development of skin g/ml propidium iodide, 0.1 mg/ml RNAse A, 0.1% NP40, and 0.1% tumors in hairless mice after discontinuation of ultraviolet irradiation. trisodium citrate. Samples were analyzed by two-dimensional flow Cancer Res. 51, 979-984. cytometry to detect both fluorescein and propidium iodide.
